Cardiac Magnetic Resonance Imaging Predicts Recovery of Left Ventricular Function in Acute Onset Cardiomyopathy

Heart Lung and Circulation

Volumn 21, Issue 1, 2012, Pages 30-35

  McLellan, Alex J A ^a,b   McKenzie, Scott C ^a,c   Taylor, Andrew J ^a  

^a ALFRED HOSPITAL   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c THE PRINCE CHARLES HOSPITAL   (Australia)

Author keywords

Cardiac magnetic resonance imaging; Cardiomyopathy; Ejection fraction; Global relative enhancement; Myocarditis; Prognosis

Indexed keywords

PENTETIC ACID;

ADULT; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CONVALESCENCE; FEMALE; FOLLOW UP; HEART EDEMA; HEART FUNCTION TEST; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE FIBROSIS; HEART MUSCLE NECROSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; CARDIOMYOPATHIES; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84855826248     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2011.09.005     Document Type: Article

References (26)

1. Cooper L.T., Berry G.J., Shabetai R. Idiopathic giant-cell myocarditis: natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med 1997, 336:1860-1866.
2. Mason J.W., O'Connell J.B., Herskowitz A., Rose N.R., McManus B.M., Billingham M.E., et al. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995, 333(5).
3. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death. Circulation 1999, 99:1091-1100.
4. Chow L.H., Radio S.J., Sears T.D., McManus B.M. Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. J Am Coll Cardiol 1989, 14:915-920.
5. Cooper L.T., Baughman K.L., Feldman A.M., Frustaci A., Jessup M., Kuhl U., et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol 2007, 50:1914-1931.
6. Pennell D.J., Sechtem U., Higgins C., Manning W., Pohost G., Rademakers F., et al. Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report. Eur Heart J 2004, 25:1940-1965.
7. Friedrich M.G., Strohm O., Schulz-Menger J., Marciniak H., Luft F.C., Dietz R. Contrast media - enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998, 97:1802-1809.
8. Abdel-Aty H., Boyé P., Zagrosek A., Wassmuth R., Kumar A., Messroghli D., et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis comparison of different approaches. J Am Coll Cardiol 2005, 45:1815-1822.
9. Laissy J.P., Messin B., Varenne O., Iung B., Karila-Cohen D., Schouman-Claeys E., et al. MRI of acute myocarditis* a comprehensive approach based on various imaging sequences. Chest 2002, 122:1638-1648.
10. Mahrholdt H., Goedecke C., Wagner A., Meinhardt G., Athanasiadis A., Vogelsberg H., et al. Cardiovascular magnetic resonance assessment of human myocarditis a comparison to histology and molecular pathology. Circulation 2004, 109:1250-1258.
11. Pfluger H., Maeder M., LaGerche A., Taylor A. One- and two-dimensional estimation of right and left ventricular size and function - comparison with cardiac magnetic resonance imaging volumetric analysis. Heart Lung Circ 2010, 19:541-548.
12. Bellenger N.G., Burgess M., Ray S.G., Lahiri A., Coats A.J., Cleland J.G., et al. Comparison of left ventricular ejection fraction and volumes in heart failure by two dimensional echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance: are they interchangeable. Eur Heart J 2000, 21:1387-1396.
13. Grothues F., Moon J.C., Bellenger N.G., Smith G.S., Klein H.U., Pennell D.J. Interstudy reproducibility of right ventricular volumes, function and mass with cardiovascular magnetic resonance. Am Heart J 2004, 147:218-223.
14. Nichols K., Adatepe M.H., Isaacs G.H., Powell O.M., Pittman D.E., Gay T.C., et al. A new scintigraphic method for determining left ventricular volumes. Circulation 1984, 70(October (4)):672-680.
15. Gopal A., Shen Z., Sapin P., Keller A.M., Schnellbaecher M.J., Leibowitz D.W., et al. Assessment of cardiac function by three-dimensional echocardiography compared with conventional noninvasive methods. Circulation 1995, 92(August 15 (4)):842-853.
16. McCrohon J.A., Moon J.C.C., Prasad S.K., McKenna W.J., Lorenz C.H., Coats A.J.S., et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003, 108(July):54-59.
17. Friedrich M., Sechtem U., Schulz-Menger J. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol 2009, 53(17).
18. Kindermann I., Kindermann M., Kandolf R., Kandolf R., Klingel K., Bültmann B., et al. Predictors of outcome in patients with suspected myocarditis. Circulation 2008, 118:639-648.
19. Kadish A., Dyer A., Daubert J.P., Quigg R., Estes M., Anderson K.P., et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004, 350:2151-2158.
20. Bristow M., Saxon L., Boehmer J., Krueger S., Kass D.A., De Marco T., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004, 350:2140-2150.
21. McCarthy R.E., Boehmer J.P., Hruban R.H., Hutchins G.M., Kasper E.K., Hare J.M., et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000, 342:690-695.
22. Bardy G.H., Lee K.L., Mark D.B., Poole J.E., Packer D.L., Boineau R., et al. Amiodarone or an implantable cardioverter defibrillator for congestive heart failure. N Engl J Med 2005, 352:225-237.
23. Hunt S., Abraham W.T., Chin M.H., Feldman A.M., Francis G.S., Ganiats T.G., et al. Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009, 53:e1-e90.
24. Zipes D., Camm A., Borggrefe M., Buxton A.E., Chaitman B., Fromer M., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. J Am Coll Cardiol 2006, 48(September 5 (5)):e247-e346.
25. Demir H., Tan Y., Kozdag G., Isgoren S., Anik Y., Ural D., et al. Comparison of gated SPECT, echocardiography and cardiac magnetic resonance imaging for the assessment of left ventricular ejection fraction and volumes. Ann Saudi Med 2007, 27(November-December (6)):415-420.
26. Mistry N., Halvorsen S., Hoffmann P., Müller C., Bøhmer E., Kjeldsen S.E., et al. Assessment of left ventricular function with magnetic resonance imaging vs. echocardiography, contrast echocardiography, and single-photon emission computed tomography in patients with recent ST-elevation myocardial infarction. Eur J Echocardiogr 2010, (June 5).